Breast-conservation may be OK for inherited cancers
Key points
- Breast-conserving therapy (BCT), which involves limited surgery and radiation, is a suitable option for young women with BRCA-associated breast cancer, the most common hereditary type of the disease, new research suggests.
- The optimal treatment of women with hereditary breast cancer remains an unsettled issue, Dr.
- To investigate, the researchers followed 87 women with BRCA-related cancer who were treated with BCT between 1992 and 2004.
- The risk of developing a repeat cancer in the same breast was 11.2 percent at 5 years and 13.6 percent at 10 years.
Breast-conserving therapy (BCT), which involves limited surgery and radiation, is a suitable option for young women with BRCA-associated breast cancer, the most common hereditary type of the disease, new research suggests. This is because the risk of cancer returning in the same breast after treatment is relatively low.
The optimal treatment of women with hereditary breast cancer remains an unsettled issue, Dr. Mark Robson and colleagues, from Memorial Sloan-Kettering Cancer Center in New York, note in the journal Cancer.
To investigate, the researchers followed 87 women with BRCA-related cancer who were treated with BCT between 1992 and 2004. The patients were around 43 years of age when first diagnosed with the cancer. Seventy-four percent of the patients were also treated with chemotherapy and 29 percent also received the anti-cancer agent tamoxifen.
The risk of developing a repeat cancer in the same breast was 11.2 percent at 5 years and 13.6 percent at 10 years.
Robson and his colleagues suggest that "BCT is a reasonable option for these women, and that the" reasons for performing complete breast removal or mastectomy in these patients shouldn't be any different from those used in women with non-hereditary forms of breast cancer.
SOURCE: Cancer, January 1, 2005.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsFox Chase scientists identify key protein players in hard-to-treat breast cancers
At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of…
2 April 2012
NewsU-M researchers find genetic rearrangements driving 5 to 7 percent of breast cancers
Researchers at the University of Michigan Comprehensive Cancer Center have discovered two cancer-spurring gene rearrangements that may trigger 5 to 7 percent of all breast cancers. These types of genetic recombinations…
21 November 2011
NewsResearchers discover that same gene has opposite effects in prostate, breast cancers
Researchers at Cleveland Clinic have discovered that a gene – known as an androgen receptor (AR) – is found in both prostate and breast cancers yet has opposite effects on these diseases. In prostate cancer, the AR gene…
